Karen H Costenbader MD MPH
Lupus & Related
Professor of Medicine, Brigham & Women's Hospital, Harvard Medical School
Join to View Full Profile
60 Fenwood RoadBrigham and Women's Hospital RheumatologyBoston, MA 02115
Phone+1 617-732-5155
Dr. Costenbader is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Karen Costenbader is a rheumatologist in Boston, MA, specializing in lupus. She completed Harvard Medical School, internal medicine residency and rheumatology fellowship at Massachusetts General Hospital. She obtained an MPH from Harvard School of Public Health. She has authored over 400 publications. She directs the Brigham and Women’s Hospital Lupus Program and Section of Clinical Sciences.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Rheumatology, 1999 - 2002
Harvard School of Public HealthMPH, 2002- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
Harvard Medical SchoolClass of 1995
Certifications & Licensure
MA State Medical License 2000 - 2027
FL State Medical License 2021 - 2024
CT State Medical License 2022 - 2023
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.Bassil Bacare, Syed Bukhari, Nathan Watson, Julia Malejczyk, Christopher Amalan
Thrombosis and Haemostasis. 2026-06-25 - Cardiometabolic protective mechanisms and efficacy of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in SLE.Youngmin Kim, April Jorge, Brittany N Weber, Karen H Costenbader
Rheumatology. 2026-06-24 - Cardiovascular Manifestations of Systemic Lupus Erythematosus: A Practical Multi-Modality Imaging Approach.Julie I H Borchsenius, Maria Dons, Morten Sengeløv, Maya Wiessman, Karen H Costenbader
The Canadian Journal of Cardiology. 2026-06-02
Journal Articles
- Association of Depression with Risk of Incident Systemic Lupus Erythematosus in Women Assessed Across 2 DecadesCandace H Feldman, Karen H Costenbader, JAMA
- Hydroxychloroquine Prescription Trends and Predictors for Excess Dosing Per Recent Ophthalmology GuidelinesS Sam Lim, Anca Askanase, Michelle Petri, Karen H Costenbader, Ronald B Melles, Cynthia Aranow, April M Jorge, BioMed Central
Other
- Non-coronary cardiac manifestations of systemic lupus erythematosus in adultsCostenbader KH, Schur PH
http://www.uptodate.com/contents/non-coronary-cardiac-manifestations-of-systemic-lupus-erythematosus
UpToDate, Wolters Kluwer Health - 2012-09-13 - Coronary heart disease in systemic lupus erythematosusCostenbader KH, Schur PH
http://www.uptodate.com/contents/coronary-heart-disease-in-systemic-lupus-erythematosus
UpToDate, Wolters Kluwer Health - 2012-08-31
Authored Content
- Dynamic Patterns and Predictors of Hydroxychloroquine Nonadherence Among Medicaid Beneficiaries with Systemic Lupus ErythematosusJanuary 2018
- Dynamic Patterns and Predictors of Hydroxychloroquine Nonadherence Among Medicaid Beneficiaries with Systemic Lupus ErythematosusJanuary 2018
Press Mentions
Lupus Foundation of America Honors Outstanding Achievements in Lupus ResearchOctober 27th, 2025- FDA Approves Third-Ever Drug for Lupus NephritisOctober 20th, 2025
- ACR Journals on AirAugust 5th, 2025
Grant Support
- GENE ENVIRONMENT TRIGGERS AND PROTEOMIC PATHWAYS MEDIATING ANTI-NUCLEAR AUTOIMMUNITY AND SYSTEMIC RHEUMATIC DISEASEUNIVERSITY OF HOUSTON2026–2031
- Dapagliflozin in Active Lupus Nephritis: A Pilot and Feasibility Randomized TrialBRIGHAM AND WOMEN'S HOSPITAL2026–2028
- Elucidating Social Determinants and Mental Health Needs to Achieve Equity in Rheumatic Disease CareBRIGHAM AND WOMEN'S HOSPITAL2023–2025
- Cardiovascular Disease Epidemiology in Patients with LupusBRIGHAM AND WOMEN'S HOSPITAL2014–2025
- Vitamin D And Fish Oil For Autoimmune Disease, Inflammation And Joint PainNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
Professional Memberships
- Member
- Clinical Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
